{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:29:35Z","timestamp":1788913775184,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejmech.2021.113441","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T01:50:58Z","timestamp":1617760258000},"page":"113441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"219","author":[{"given":"Lailiang","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fucheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113441_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A\u00a0century of Alzheimer\u2019s disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113441_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113441_bib4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u00a0beta oligomers - a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2021.113441_bib5","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1523\/JNEUROSCI.5161-07.2008","article-title":"Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization","volume":"28","author":"Klyubin","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2021.113441_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2021.113441_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer\u2019s disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib8","doi-asserted-by":"crossref","first-page":"316523","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of Alzheimer\u2019s disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ejmech.2021.113441_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113441_bib10","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The beta-secretase enzyme BACE in health and Alzheimer\u2019s disease: regulation, cell biology, function, and therapeutic potential","volume":"29","author":"Vassar","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2021.113441_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.redox.2016.10.003","article-title":"Nrf2 mediates redox adaptations to exercise","volume":"10","author":"Done","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.ejmech.2021.113441_bib12","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1305687110","article-title":"Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex","volume":"110","author":"Baird","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113441_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","article-title":"The cytoprotective role of the Keap1-Nrf2 pathway","volume":"85","author":"Baird","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113441_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.256","article-title":"Nrf2: new insight in cell apoptosis","volume":"6","author":"Bonay","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113441_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113441_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/ars.2008.2242","article-title":"The Nrf2\/ARE pathway as a potential therapeutic target in neurodegenerative disease","volume":"11","author":"Calkins","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2021.113441_bib17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.freeradbiomed.2008.09.001","article-title":"Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?","volume":"45","author":"de Vries","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2015.07.147","article-title":"Nrf2--a therapeutic target for the treatment of neurodegenerative diseases","volume":"88","author":"Johnson","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/iub.1466","article-title":"Biological activity of selenium: Revisited","volume":"68","author":"Wrobel","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejmech.2021.113441_bib20","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1083516","article-title":"Characterization of mammalian selenoproteomes","volume":"300","author":"Kryukov","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113441_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1152\/physrev.00039.2013","article-title":"Selenoproteins: molecular pathways and physiological roles","volume":"94","author":"Labunskyy","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113441_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.01854.x","article-title":"Selenium and selenoproteins in the brain and brain diseases","volume":"86","author":"Chen","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2021.113441_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0531-5565(00)00218-7","article-title":"Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians\/centenarians","author":"Savarinoa","year":"2001","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejmech.2021.113441_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/acs.jmedchem.9b01152","article-title":"Development and therapeutic potential of Selenazo compounds","volume":"63","author":"Ruberte","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113441_bib25","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.3390\/ijms18102209","article-title":"A\u00a0summary of new Findings on the Biological effects of selenium in selected animal species-A Critical review","volume":"18","author":"Hosnedlova","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113441_bib26","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1021\/ja00197a065","article-title":"Development of synthetic compounds with glutathione peroxidase activity","volume":"111","author":"Wilson","year":"1989","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113441_bib27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bcp.2013.08.028","article-title":"The early research and development of ebselen","volume":"86","author":"Parnham","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113441_bib28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0306-3623(95)00003-J","article-title":"Molecular Actions of ebselen-an Antiinflammatory antioxidant","volume":"26","author":"Schewe","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113441_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0891-5849(02)01180-2","article-title":"Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia","volume":"34","author":"Imai","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0891-5849(02)00954-1","article-title":"Role of oxygen and nitrogen species in experimental uveitis: anti-inflammatory activity of the synthetic antioxidant ebselen","volume":"33","author":"Bosch-momrell","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib31","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0891-5849(03)00360-5","article-title":"Regulation of intrinsic prion protein by growth factors and tnf-\u03b1: the role of intracellular reactive oxygen species","volume":"35","author":"Sauer","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib32","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/tx0601105","article-title":"Ebselen, a Seleno-organic antioxidant, as an electrophile","volume":"19","author":"Sakurai","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113441_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/antiox9060551","article-title":"Esculetin as a Bifunctional antioxidant prevents and Counteracts the oxidative stress and neuronal death induced by amyloid protein in SH-SY5Y cells","volume":"9","author":"Pruccoli","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2021.113441_bib34","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.freeradbiomed.2012.06.023","article-title":"Validation of the multiple sensor mechanism of the Keap1-Nrf2 system","volume":"53","author":"Takaya","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib35","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/acschemneuro.9b00106","article-title":"Selenepezil, a selenium-containing compound, exerts neuroprotective effect via modulation of the Keap1-nrf2-ARE pathway and attenuates abeta-induced cognitive impairment in\u00a0Vivo","volume":"10","author":"Yan","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113441_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/med.21622","article-title":"BACE1 inhibitors: Current status and future directions in treating Alzheimer\u2019s disease","volume":"40","author":"Moussa-Pacha","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113441_bib37","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1021\/acs.jmedchem.6b00307","article-title":"Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-A beta-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of alzheimer\u2019s disease","volume":"59","author":"Scott","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113441_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS b-amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib39","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113441_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drudis.2011.08.002","article-title":"The role of fragment-based and computational methods in polypharmacology","volume":"17","author":"Bottegoni","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2021.113441_bib41","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1021\/acs.joc.7b00440","article-title":"Thermal and photoinduced copper-promoted C-Se bond formation: Synthesis of 2-Alkyl-1,2-benzisoselenazol-3(2H)-ones and evaluation against Mycobacterium tuberculosis","volume":"82","author":"Thanna","year":"2017","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113441_bib42","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00216-011-4963-x","article-title":"Beta-secretase as a target for Alzheimer\u2019s disease drug discovery: an overview of in\u00a0vitro methods for characterization of inhibitors","volume":"400","author":"Mancini","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejmech.2021.113441_bib43","doi-asserted-by":"crossref","first-page":"112433","DOI":"10.1016\/j.jep.2019.112433","article-title":"Notopterygium incisum extract (NRE) rescues cognitive deficits in APP\/PS1 Alzhneimer\u2019s disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology","volume":"249","author":"Jiang","year":"2020","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113441_bib44","doi-asserted-by":"crossref","first-page":"13138","DOI":"10.1523\/JNEUROSCI.4790-12.2013","article-title":"Arctigenin effectively ameliorates memory impairment in Alzheimer\u2019s disease model mice targeting both beta-amyloid production and clearance","volume":"33","author":"Zhu","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2021.113441_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2131\/jts.43.659","article-title":"Melatonin antagonizes oxidative stress-induced mitochondrial dysfunction in retinal pigmented epithelium cells via melatonin receptor 1 (MT1)","volume":"43","author":"Yan","year":"2018","journal-title":"J.\u00a0Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2021.113441_bib46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.318.5849.384","article-title":"Alzheimer\u2019s disease. Fresh evidence points to an old suspect: calcium","volume":"318","author":"Marx","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113441_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuron.2008.07.013","article-title":"Linking calcium to Abeta and Alzheimer\u2019s disease","volume":"59","author":"Green","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2021.113441_bib48","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1021\/acs.jmedchem.5b00410","article-title":"Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents","volume":"58","author":"Peng","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113441_bib49","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.bcp.2010.07.014","article-title":"Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential","volume":"80","author":"Paine","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113441_bib50","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1021\/jm400224q","article-title":"Keap calm, and carry on covalently","volume":"56","author":"Wilson","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113441_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:27:31Z","timestamp":1759328851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421002907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":51,"alternative-id":["S0223523421002907"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113441","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113441"}}